Why Challenge Trials of SARS-CoV-2 Vaccines Could Be Ethical Despite Risk of Severe Adverse Events

Research output: Contribution to journalArticle

1 Scopus citations

Fingerprint Dive into the research topics of 'Why Challenge Trials of SARS-CoV-2 Vaccines Could Be Ethical Despite Risk of Severe Adverse Events'. Together they form a unique fingerprint.

Medicine & Life Sciences

Social Sciences